Multipurpose peptides: The venoms of Amazonian stinging ants contain anthelmintic ponericins with diverse predatory and defensive activities
- PMID: 34302796
- PMCID: PMC10167921
- DOI: 10.1016/j.bcp.2021.114693
Multipurpose peptides: The venoms of Amazonian stinging ants contain anthelmintic ponericins with diverse predatory and defensive activities
Abstract
In the face of increasing drug resistance, the development of new anthelmintics is critical for controlling nematodes that parasitise livestock. Although hymenopteran venom toxins have attracted attention for applications in agriculture and medicine, few studies have explored their potential as anthelmintics. Here we assessed hymenopteran venoms as a possible source of new anthelmintic compounds by screening a panel of ten hymenopteran venoms against Haemonchus contortus, a major pathogenic nematode of ruminants. Using bioassay-guided fractionation coupled with liquid chromatography-tandem mass spectrometry, we identified four novel anthelmintic peptides (ponericins) from the venom of the neotropical ant Neoponera commutata and the previously described ponericin M-PONTX-Na1b from Neoponera apicalis venom. These peptides inhibit H. contortus development with IC50 values of 2.8-5.6 μM. Circular dichroism spectropolarimetry indicated that the ponericins are unstructured in aqueous solution but adopt α-helical conformations in lipid mimetic environments. We show that the ponericins induce non-specific membrane perturbation, which confers broad-spectrum antimicrobial, insecticidal, cytotoxic, hemolytic, and algogenic activities, with activity across all assays typically correlated. We also show for the first time that ponericins induce spontaneous pain behaviour when injected in mice. We propose that the broad-spectrum activity of the ponericins enables them to play both a predatory and defensive role in neoponeran ants, consistent with their high abundance in venom. This study reveals a broader functionality for ponericins than previously assumed, and highlights both the opportunities and challenges in pursuing ant venom peptides as potential therapeutics.
Keywords: Ant; Anthelmintic; Antimicrobial; Pain; Ponericin; Venom peptide.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures








References
-
- Peters RS, Krogmann L, Mayer C, Donath A, Gunkel S, Meusemann K, Kozlov A. Podsiadlowski L, Petersen M, Lanfear R, Diez PA. Heraty J, Kjer KM, Klopfstein S, Meier R, Polidori C, Schmitt T, Liu S, Zhou X, Wappler T, Rust J, Misof B, Niehuis O, Evolutionary history of the Hymenoptera, Curr. Biol 27 (7) (2017) 1013–1018. - PubMed
-
- Aili SR, Touchard A, Escoubas P, Padula MP, Orivel J, Dejean A, Nicholson GM, Diversity of peptide toxins from stinging ant venoms, Toxicon 92 (2014) 166–178. - PubMed
-
- Otti O, Tragust S, Feldhaar H, Unifying external and internal immune defences, Trends Ecol. Evol 29 (11) (2014) 625–634. - PubMed
-
- LeBrun EG, Diebold PJ, Orr MR, Gilbert LE, Widespread chemical detoxification of alkaloid venom by formicine ants, J. Chem. Ecol 41 (10) (2015) 884–895. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases